跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EXTRA STRENGTH BENADRYL ALLERGY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
EXTRA STRENGTH BENADRYL ALLERGY
Authorized
STANDARD
EXTRA STRENGTH BENADRYL ALLERGY
mcneil consumer healthcare division of johnson & johnson inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2a5312af7a632785
Company
mcneil consumer healthcare division of johnson & johnson inc
Type
Standard
Approval Details
Approval Id
2a5312af7a632785
Drug Approval Canada Name
EXTRA STRENGTH BENADRYL ALLERGY
Product Name
EXTRA STRENGTH BENADRYL ALLERGY
Status
Marketed
Status Date
2018-03-26
Original Market Date
2018-03-26
Din
02470144
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
04:04.04
Atc Original
R06AA02 DIPHENHYDRAMINE
Atc Name
r 06 aa 02
Aig Number
0102639001
Company Name
mcneil consumer healthcare division of johnson & johnson inc
Company Address
88 Mcnabb Street, Markham, Ontario, Canada, L3R 5L2
Active Ingredients
DIPHENHYDRAMINE HYDROCHLORIDE
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2a5312af7a632785
Type
Standard
Back to Health Canada Approvals